Skip to main content
. Author manuscript; available in PMC: 2013 Aug 6.
Published in final edited form as: J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):331–339. doi: 10.1176/appi.neuropsych.11080192

Table 3.

Multiple Regressions Predicting Neurobehavioral Symptoms and IADL Declines

F β Adj. R2 p
FrSBe Total 4.39 - .08 .002
 MA group - −.24 - .003
 LT alcohol dependence - −.18 - .029
 LT cocaine dependence - .02 - .850
 LT cannabis dependence - .15 - .063
FrSBe Executive Dysfunction 5.89 - .11 <.001
 MA group - −.28 - <.001
 LT alcohol dependence - −.21 - .014
 LT cocaine dependence - .04 - .636
 LT cannabis dependence - .16 - .045
FrSBe Disinhibition 4.76 - .09 .001
 MA group - −.26 - .002
 LT alcohol dependence - −.16 - .060
 LT cocaine dependence - −.04 - .586
 LT cannabis dependence - .07 - .359
FrSBe Apathy 1.77 - .02 .136
 MA group - −.14 - .085
 LT alcohol dependence - −.10 - .220
 LT cocaine dependence - .07 - .421
 LT cannabis dependence - .16 - .059
IADL Declinea 4.75 - .20 <.001
 Total FrSBe T-score - .37 - .002
 GDS - .14 - .220
 Last MA use (days) - −.02 - .845
 HCV status - .08 - .458
 LT MDD - −.20 - .087

Note. LT = lifetime; FrSBe = Frontal Systems Behavioral Scale; MDD = Major Depressive Disorder; GDS = Global deficit score; HCV = Hepatitis C virus; IADL = Instrumental activities of daily living; MA = methamphetamine;

a

MA+ group only (n = 73).